AnaptysBio Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ANAB
Share price (9/16/26): $54.31
Market cap (9/16/26): $1.608 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 72 pages Separation and Distribution Agreement by and Among Anaptysbio, Inc. And, First Tracks Biotherapeutics, Inc. Dated as of April 20, 2026

from 8-K 59 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because the Information Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Confidential Execution Version Royalty Purchase Agreement Between Anaptysbio, Inc. and Sagard Healthcare Royalty Partners, LP Dated as of October 25, 2021